CMO

Research and development

Polipharm defines Research and Development (R&D) activities as “New Product Creation”. The group’s organization strives to develop multisource (generic drugs) pharmaceutical products from the initial development through marketing to support our country.

Multisource pharmaceutical products are pharmaceutically equivalent or pharmaceutical alternative products. Pharmaceutical products that are therapeutically equivalent are interchangeable. Therefore, the patients could afford higher quality products with reasonable expense.

Our product development capabilities span the areas of formulations Development, Intellectual property Management Analytical chemistry, Polymorphism, Project management and Regulation science.

Our teams are capable to support both domestic and international companies who looking forward for new products.